期刊信息查詢系統

期刊標題檢索 YONAGO ACTA MED 最新評論: If the main body has been completed, it is recommended to start with t... (2021-12-30)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[YONAGO ACTA MEDICA]您好，您是該頁面的第 15694 位訪客。

期刊簡介

期刊名稱

YONAGO ACTA MEDICA
LetPub Score

5.0

50 ratings

Rate

Reputation

6.4

Influence

3.4

Speed

7.0

期刊簡稱

YONAGO ACTA MED

ISSN

0513-5710

E-ISSN

1346-8049

h-index

CiteScore

SJR

SNIP

CiteScore Rank

1.60

0.279

0.655

Subject field	Quartiles	Rank	Percentile
Category: Medicine Subcategory: General Medicine	Q2	275 / 636

自引率 (2023-2024)

11.10%自引率趨勢

掲載範囲

Yonago Acta Medica (YAM) is an electronic journal specializing in medical sciences, published by Tottori University Medical Press, 86 Nishi-cho, Yonago 683-8503, Japan.

The subject areas cover the following: molecular/cell biology; biochemistry; basic medicine; clinical medicine; veterinary medicine; clinical nutrition and food sciences; medical engineering; nursing sciences; laboratory medicine; clinical psychology; medical education.

Basically, contributors are limited to members of Tottori University and Tottori University Hospital. Researchers outside the above-mentioned university community may also submit papers on the recommendation of a professor, an associate professor, or a junior associate professor at this university community.

Articles are classified into four categories: review articles, original articles, patient reports, and short communications.

官方網站

http://www.lib.tottori-u.ac.jp/yam/yam.html

在線稿件提交

http://www.lib.tottori-u.ac.jp/yam/guide.html

開放訪問

出版商

Tottori University Faculty of Medicine

主題領域

MEDICINE, RESEARCH & EXPERIMENTAL

出版國/地區

JAPAN

發行頻率

半年刊行

創刊年

1954

每年文章數

63每年文章數趨勢

黃金OA百分比

98.71%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q4

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q4	158/189

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0513-5710%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions

競爭力 *

來自作者的數據: Easy

參考鏈接

相關期刊	【YONAGO ACTA MEDICA】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
CA-A CANCER JOURNAL FOR CLINICIANS	H-index: 144 CiteScore: 873.20
NATURE REVIEWS DRUG DISCOVERY	H-index: 289 CiteScore: 137.40
LANCET	H-index: 700 CiteScore: 148.10
NEW ENGLAND JOURNAL OF MEDICINE	H-index: 933 CiteScore: 145.40
Nature Reviews Clinical Oncology	H-index: 127 CiteScore: 99.40
Nature Reviews Disease Primers	H-index: 48 CiteScore: 76.70
NATURE REVIEWS CANCER	H-index: 396 CiteScore: 111.90
NATURE REVIEWS IMMUNOLOGY	H-index: 351 CiteScore: 93.40
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION	H-index: 622 CiteScore: 48.20
World Psychiatry	H-index: 70 CiteScore: 64.10

學科內最受檢索的期刊	頁面查看次數
MEDICINE	640684
BIOMATERIALS	569250
BIOMEDICINE & PHARMACOTHERAPY	498318
Frontiers in Pharmacology	486581
Journal of Materials Chemistry B	476053
JOURNAL OF ETHNOPHARMACOLOGY	475384
Frontiers in Immunology	457830
COLLOIDS AND SURFACES B-BIOINTERFACES	419204
COMPUTERS IN BIOLOGY AND MEDICINE	416220
Frontiers in Oncology	413337

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[YONAGO ACTA MEDICA] 的評論	撰寫評論

作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 13:12:38 評論於 If the main body has been completed, it is recommended to start with the results first. If the main results are still in progress, you can start with the methods and introduction first (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 08:42:51 評論於 This varies from person to person. If the main results have been completed, it is generally recommended to start with the results. If the main results are still in progress, it is ok to start with the methods and introduction (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 平原文波領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 12:09:08 評論於 Why is it recommended to start writing a research article from the results section? Is it possible to start from the methods section? (0) 讚！ \| 平原文波
作者: 北国博达領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 11:20:23 評論於 What is the usual writing order for a research article? (0) 讚！ \| 北国博达
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-07-14 12:24:17 評論於 In any case, looking at the current situation, there won't be any changes. As long as it doesn't fall, that's enough (0) 讚！ \| 凌霄高洁

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [YONAGO ACTA MEDICA] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 13:12:38 評論於 If the main body has been completed, it is recommended to start with the results first. If the main results are still in progress, you can start with the methods and introduction first (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 08:42:51 評論於 This varies from person to person. If the main results have been completed, it is generally recommended to start with the results. If the main results are still in progress, it is ok to start with the methods and introduction (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 平原文波領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 12:09:08 評論於 Why is it recommended to start writing a research article from the results section? Is it possible to start from the methods section? (0) 讚！ \| 平原文波
作者: 北国博达領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 11:20:23 評論於 What is the usual writing order for a research article? (0) 讚！ \| 北国博达
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-07-14 12:24:17 評論於 In any case, looking at the current situation, there won't be any changes. As long as it doesn't fall, that's enough (0) 讚！ \| 凌霄高洁

首頁上一頁 1 下一頁末頁 (頁 /1)

YONAGO ACTA MEDICA

期刊標題檢索 YONAGO ACTA MED 最新評論: If the main body has been completed, it is recommended to start with t... (2021-12-30)

[YONAGO ACTA MEDICA]您好，您是該頁面的第 15694 位訪客。

開始撰寫 [YONAGO ACTA MEDICA] 的評論：

Contact us